Stocks
Axsome Therapeutics (AXSM) Cash US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Cash, bln rub | 86.5 | 200.8 | 386.2 | 315.4 | 322.9 | 305.1 | |||
| Changes by years, y/y, % | -53% | +132% | +92% | -18% | +2% | +11.9% | |||
Axsome Therapeutics. Cash, bln rub
Axsome Therapeutics. Cash, changes, %
Axsome Therapeutics (AXSM) Cash US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Cash, bln rub | 300.9 | 303.0 | 325.3 | 322.9 | 305.1 | 305.1 | ||
| Changes by years, y/y, % | -9% | -4% | -1% | +2% | +1% | |||
| Changes by quarters, q/q, % | -5% | +1% | +7% | -1% | -6% | |||
